These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1869982)

  • 1. Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.
    Michelot JM; Moreau MF; Labarre PG; Madelmont JC; Veyre AJ; Papon JM; Parry DF; Bonafous JF; Boire JY; Desplanches GG
    J Nucl Med; 1991 Aug; 32(8):1573-80. PubMed ID: 1869982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.
    John CS; Bowen WD; Saga T; Kinuya S; Vilner BJ; Baumgold J; Paik CH; Reba RC; Neumann RD; Varma VM
    J Nucl Med; 1993 Dec; 34(12):2169-75. PubMed ID: 8254405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.
    Moins N; Papon J; Seguin H; Gardette D; Moreau MF; Labarre P; Bayle M; Michelot J; Gramain JC; Madelmont JC; Veyre A
    Nucl Med Biol; 2001 Oct; 28(7):799-808. PubMed ID: 11578901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
    Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
    J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma.
    Brandau W; Niehoff T; Pulawski P; Jonas M; Dutschka K; Sciuk J; Coenen HH; Schober O
    J Nucl Med; 1996 Nov; 37(11):1865-71. PubMed ID: 8917194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.
    Moreau MF; Michelot J; Papon J; Bayle M; Labarre P; Madelmont JC; Parry D; Boire JY; Moins N; Seguin H
    Nucl Med Biol; 1995 Aug; 22(6):737-47. PubMed ID: 8535334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
    Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
    Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
    Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
    J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodide benzamides for the in-vivo detection of melanoma and metastases.
    Edreira MM; Pozzi OR
    Melanoma Res; 2006 Feb; 16(1):37-43. PubMed ID: 16432454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
    Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
    J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting.
    Labarre P; Papon J; Moreau MF; Moins N; Veyre A; Madelmont JC
    Eur J Nucl Med; 1999 May; 26(5):494-8. PubMed ID: 10382093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biologic evaluation of I-123-labeled porphyrin derivative as a potential tumor-imaging agent.
    Lee JH; Moon BS; Lee TS; Chi DY; Chun KS; Cheon GJ
    Cancer Biother Radiopharm; 2007 Dec; 22(6):853-62. PubMed ID: 18158777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
    Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
    J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perspectives of scintigraphic diagnosis of malignant lymphoma using a new radiopharmaceutical].
    Meyniel G; Michelot J; Moreau MF; Veyre A
    C R Acad Sci III; 1990; 311(1):13-8. PubMed ID: 2125523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biodistribution of 99mTC-HMPAO in healthy rats and B16 melanoma carriers].
    Calderón CF; Collazo A; Cepero W; Rodríguez JC; Montalvo M; Robustillo M; Avila A; Pérez RM
    Rev Esp Med Nucl; 1999 Dec; 18(6):425-30. PubMed ID: 10611568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of malignant melanoma with iodine-123 iodoamphetamine.
    Cohen MB; Saxton RE; Lake RR; Cagle L; Graham LS; Nizze A; Yamada LS; Gan M; Bronca G; Greenwell K
    J Nucl Med; 1988 Jul; 29(7):1200-6. PubMed ID: 3392580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
    Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
    J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
    Michelot JM; Moreau MF; Veyre AJ; Bonafous JF; Bacin FJ; Madelmont JC; Bussiere F; Souteyrand PA; Mauclaire LP; Chossat FM
    J Nucl Med; 1993 Aug; 34(8):1260-6. PubMed ID: 8326382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma.
    John CS; Saga T; Kinuya S; Le N; Jeong JM; Paik CH; Reba RC; Varma VM; McAfee JG
    Nucl Med Biol; 1993 Jan; 20(1):75-9. PubMed ID: 8461882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.